Harnessing the biology of IL-7 for therapeutic application
Reads0
Chats0
TLDR
The biology of IL-7 and the results of its clinical use that are available so far are summarized to provide a perspective on the opportunities for clinical application of this cytokine.Abstract:
Interleukin-7 (IL-7) is required for T cell development and for maintaining and restoring homeostasis of mature T cells. IL-7 is a limiting resource under normal conditions, but it accumulates during lymphopaenia, leading to increased T cell proliferation. The administration of recombinant human IL-7 to normal or lymphopenic mice, non-human primates and humans results in widespread T cell proliferation, increased T cell numbers, modulation of peripheral T cell subsets and increased T cell receptor repertoire diversity. These effects raise the prospect that IL-7 could mediate therapeutic benefits in several clinical settings. This Review summarizes the biology of IL-7 and the results of its clinical use that are available so far to provide a perspective on the opportunities for clinical application of this cytokine.read more
Citations
More filters
Journal ArticleDOI
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
TL;DR: Biomarker-guided immunotherapy that is administered to patients at the proper immune phase of sepsis is potentially a major advance in the treatment of septicaemia and in the field of infectious disease.
Journal ArticleDOI
Adoptive immunotherapy for cancer: harnessing the T cell response
TL;DR: Progress in the use of adoptively transferred T cells is discussed, focusing on how they can mediate tumour cell eradication, including more accurate targeting of antigens expressed by tumours and the associated vasculature.
Journal ArticleDOI
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
TL;DR: It is hypothesised that immunoadjuvant therapy represents the next major advance in sepsis, and explains why many previous sepsi trials which were directed at blocking inflammatory mediators or pathogen recognition signalling pathways failed.
Journal ArticleDOI
The immunopathology of sepsis and potential therapeutic targets
TL;DR: Pivotal for the clinical development of new sepsis therapies is the selection of patients on the basis of biomarkers and/or functional defects that provide specific insights into the expression or activity of the therapeutic target.
References
More filters
Journal ArticleDOI
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Weihong Liu,Amy L. Putnam,Zhou Xu-yu,Gregory L. Szot,Michael R. Lee,Shirley Zhu,Peter A. Gottlieb,Philipp Kapranov,Thomas R. Gingeras,Barbara Fazekas de St Groth,Carol Clayberger,David M. Soper,Steven F. Ziegler,Jeffrey A. Bluestone +13 more
TL;DR: It is found that the IL-7 receptor (CD127) is down-regulated on a subset of CD4+ T cells in peripheral blood and can be used to quantitate T reg cell subsets in individuals with type 1 diabetes supporting the use of CD127 as a biomarker for human T reg cells.
Journal ArticleDOI
Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells
TL;DR: Increased expression of the interleukin 7 receptor α-chain (IL-7Rα) identifies the effector CD8 T cells that will differentiate into memory cells, and this marker may be useful in predicting the number of memory T cells generated after infection or immunization.
Journal ArticleDOI
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo.
TL;DR: The naïve and memory T lymphocyte pools are maintained through poorly understood homeostatic mechanisms that may include signaling via cytokine receptors, and shows that interleukin-7 (IL-7) plays multiple roles in regulating homeostasis of CD8+ T cells.
Journal ArticleDOI
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells
Nabila Seddiki,Nabila Seddiki,Brigitte Santner-Nanan,Jeff Martinson,John Zaunders,Sarah C. Sasson,Alan L. Landay,Michael J. Solomon,Warwick Selby,Stephen I. Alexander,Ralph Nanan,Anthony D. Kelleher,Barbara Fazekas de St Groth +12 more
TL;DR: Cell surface expression of CD127 allows accurate estimation of T reg cell numbers and isolation of pure populations for in vitro studies and should contribute to the understanding of regulatory abnormalities in immunopathic diseases.
Journal ArticleDOI
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
Marina Cella,Anja Fuchs,William Vermi,Fabio Facchetti,Karel Otero,Jochen K. Lennerz,Jason M. Doherty,Jason C. Mills,Marco Colonna +8 more
TL;DR: The characterization of a human NK cell subset located in mucosa-associated lymphoid tissues, such as tonsils and Peyer’s patches, which is hard-wired to secrete interleukin (IL)-22, IL-26 and leukaemia inhibitory factor is reported.
Related Papers (5)
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
Claude Sportes,Frances T. Hakim,Sarfraz Memon,Hua Zhang,Kevin S. Chua,Margaret R. Brown,Thomas A. Fleisher,Michael Krumlauf,Rebecca Babb,Catherine Chow,Terry J. Fry,Julie Engels,Renaud Buffet,Michel Morre,Robert J. Amato,David Venzon,Robert Korngold,Andrew L. Pecora,Ronald E. Gress,Crystal L. Mackall +19 more